Terry specialises in OTC derivatives and a variety of structured products, including equity and credit linked structures, repackagings, fund linked derivatives, ISDA close-outs and hedging. He is ranked in Chambers Asia Pacific and is particularly recognised for his expertise in OTC derivatives regulatory reforms. Terry has advised regulators, industry groups and a wide variety of clients on issues relating to reporting, clearing and margining of OTC derivatives.